Cargando…

Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors

Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA-ECMO have been contradictory. We evaluated the aggregate short-term mortality after VA-ECMO and predictive factors in patients with F...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishram-Nielsen, Julie K. K., Foroutan, Farid, Rizwan, Saima, Peck, Serena S., Bodack, Julia, Orchanian-Cheff, Ani, Gustafsson, Finn, Ross, Heather J., Fan, Eddy, Rao, Vivek, Billia, Filio, Alba, Ana Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540286/
https://www.ncbi.nlm.nih.gov/pubmed/36205853
http://dx.doi.org/10.1007/s10741-022-10277-z
_version_ 1784803678252695552
author Vishram-Nielsen, Julie K. K.
Foroutan, Farid
Rizwan, Saima
Peck, Serena S.
Bodack, Julia
Orchanian-Cheff, Ani
Gustafsson, Finn
Ross, Heather J.
Fan, Eddy
Rao, Vivek
Billia, Filio
Alba, Ana Carolina
author_facet Vishram-Nielsen, Julie K. K.
Foroutan, Farid
Rizwan, Saima
Peck, Serena S.
Bodack, Julia
Orchanian-Cheff, Ani
Gustafsson, Finn
Ross, Heather J.
Fan, Eddy
Rao, Vivek
Billia, Filio
Alba, Ana Carolina
author_sort Vishram-Nielsen, Julie K. K.
collection PubMed
description Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA-ECMO have been contradictory. We evaluated the aggregate short-term mortality after VA-ECMO and predictive factors in patients with FM. We systematically searched in electronic databases (February 2022) to identify studies evaluating short-term mortality (defined as mortality at 30 days or in-hospital) after VA-ECMO support for FM. We included studies with 5 or more patients published after 2009. We assessed the quality of the evidence using the QUIPS and GRADE tools. Mortality was pooled using random effect models. We performed meta-regression to explore heterogeneity based on a priori defined factors. We included 54 observational studies encompassing 2388 FM patients supported with VA-ECMO. Median age was 41 years (25th to 75th percentile 37–47), and 50% were female. The pooled short-term mortality was 35% (95% CI 29–40%, I(2) = 69%; moderate certainty). By meta-regression, studies with younger populations showed lower mortality. Female sex, receiving a biopsy, cardiac arrest, left ventricular unloading, and earlier recruitment time frame, did not explain heterogeneity. These results remained consistent regardless of continent and the risk of bias category. In individual studies, low pH value, high lactate, absence of functional cardiac recovery on ECMO, increased burden of malignant arrhythmia, high peak coronary markers, and IVIG use were identified as independent predictors of mortality. When conventional therapies have failed, especially in younger patients, cardiopulmonary support with VA-ECMO should be considered in the treatment of severe FM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10741-022-10277-z.
format Online
Article
Text
id pubmed-9540286
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-95402862022-10-11 Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors Vishram-Nielsen, Julie K. K. Foroutan, Farid Rizwan, Saima Peck, Serena S. Bodack, Julia Orchanian-Cheff, Ani Gustafsson, Finn Ross, Heather J. Fan, Eddy Rao, Vivek Billia, Filio Alba, Ana Carolina Heart Fail Rev Article Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA-ECMO have been contradictory. We evaluated the aggregate short-term mortality after VA-ECMO and predictive factors in patients with FM. We systematically searched in electronic databases (February 2022) to identify studies evaluating short-term mortality (defined as mortality at 30 days or in-hospital) after VA-ECMO support for FM. We included studies with 5 or more patients published after 2009. We assessed the quality of the evidence using the QUIPS and GRADE tools. Mortality was pooled using random effect models. We performed meta-regression to explore heterogeneity based on a priori defined factors. We included 54 observational studies encompassing 2388 FM patients supported with VA-ECMO. Median age was 41 years (25th to 75th percentile 37–47), and 50% were female. The pooled short-term mortality was 35% (95% CI 29–40%, I(2) = 69%; moderate certainty). By meta-regression, studies with younger populations showed lower mortality. Female sex, receiving a biopsy, cardiac arrest, left ventricular unloading, and earlier recruitment time frame, did not explain heterogeneity. These results remained consistent regardless of continent and the risk of bias category. In individual studies, low pH value, high lactate, absence of functional cardiac recovery on ECMO, increased burden of malignant arrhythmia, high peak coronary markers, and IVIG use were identified as independent predictors of mortality. When conventional therapies have failed, especially in younger patients, cardiopulmonary support with VA-ECMO should be considered in the treatment of severe FM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10741-022-10277-z. Springer US 2022-10-07 2023 /pmc/articles/PMC9540286/ /pubmed/36205853 http://dx.doi.org/10.1007/s10741-022-10277-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Vishram-Nielsen, Julie K. K.
Foroutan, Farid
Rizwan, Saima
Peck, Serena S.
Bodack, Julia
Orchanian-Cheff, Ani
Gustafsson, Finn
Ross, Heather J.
Fan, Eddy
Rao, Vivek
Billia, Filio
Alba, Ana Carolina
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
title Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
title_full Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
title_fullStr Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
title_full_unstemmed Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
title_short Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
title_sort patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540286/
https://www.ncbi.nlm.nih.gov/pubmed/36205853
http://dx.doi.org/10.1007/s10741-022-10277-z
work_keys_str_mv AT vishramnielsenjuliekk patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT foroutanfarid patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT rizwansaima patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT peckserenas patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT bodackjulia patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT orchaniancheffani patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT gustafssonfinn patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT rossheatherj patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT faneddy patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT raovivek patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT billiafilio patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors
AT albaanacarolina patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors